The Endocrinology, Diabetes & Metabolism Hong Kong (EDMHK) 2nd Annual Meeting
The Endocrinology, Diabetes & Metabolism Hong Kong (EDMHK) 2019 meeting held on 26th – 27th October 2019 was jointly organised by the University of Hong Kong and Queen Mary Hospital. The EDMHK aimed to provide a new platform for practicing clinicians to share with each other the most updated and comprehensive knowledge on diabetes, as well as other endocrine disorders such as obesity, osteoporosis and metabolic diseases. The event included not only lectures and illustrative cases sharing, but also booth displays by local medical and pharmaceutical companies.
Prof. Richard Gilbert presented the role of SGLT2 Inhibitor beyond glucose control
Dr. Paul Lee illustrated the clinical significance of liver fibrosis in diabetes
Booth displays by local medical and pharmaceutical companies
